Publicaciones en colaboración con investigadores/as de Instituto Oftalmologico de Alicante (41)

2014

  1. Author response: Choroidal thickness and axial length

    Investigative Ophthalmology and Visual Science

  2. Direct comparison of spectral-domain and swept-source OCT in the measurement of choroidal thickness in normal eyes

    British Journal of Ophthalmology, Vol. 98, Núm. 3, pp. 334-338

  3. Macular choroidal thickness profile in a healthy population measured by swept-source optical coherence tomography

    Investigative Ophthalmology and Visual Science, Vol. 55, Núm. 6, pp. 3532-3542

2013

  1. Intravitreal anti-VEGF therapy for choroidal neovascularisation secondary to pathological myopia: 4-Year outcome

    British Journal of Ophthalmology, Vol. 97, Núm. 11, pp. 1447-1450

  2. Intravitreal drug dispersion and needle gauge

    Acta Ophthalmologica

  3. Macular choroidal thickness in normal pediatric population measured by swept-source optical coherence tomography

    Investigative Ophthalmology and Visual Science, Vol. 54, Núm. 1, pp. 353-359

  4. Reply

    Retina

  5. Spectral-domain optical coherence tomography study of macular structure as prognostic and determining factor for macular hole surgery outcome

    Retina, Vol. 33, Núm. 6, pp. 1117-1122

  6. Systemic beta-blockers may reduce the need for repeated intravitreal injections in patients with wet age-related macular degeneration treated by bevacizumab

    Retina, Vol. 33, Núm. 3, pp. 508-512

2012

  1. Intravitreal ranibizumab, with or without filter?

    Acta Ophthalmologica

  2. Restoration of macular structure as the determining factor for macular hole surgery outcome

    Graefe's Archive for Clinical and Experimental Ophthalmology, Vol. 250, Núm. 10, pp. 1409-1414

  3. Retinal thickness changes following photodynamic therapy in chronic central serous chorioretinopathy

    Graefe's Archive for Clinical and Experimental Ophthalmology, Vol. 250, Núm. 6, pp. 803-808

  4. Three versus one intravitreal bevacizumab injections as initial protocol to treat myopic choroidal neovascularization

    Acta Ophthalmologica

2011

  1. Intravitreal bevacizumab to treat choroidal neovascularization following photodynamic therapy in central serous choroidopathy

    European Journal of Ophthalmology, Vol. 21, Núm. 4, pp. 503-505

  2. Myopic choroidal neovascularization treated by intravitreal bevacizumab: Comparison of two different initial doses

    Graefe's Archive for Clinical and Experimental Ophthalmology, Vol. 249, Núm. 4, pp. 595-599

  3. Sliding macular fold following retinal detachment surgery

    Graefe's Archive for Clinical and Experimental Ophthalmology, Vol. 249, Núm. 2, pp. 301-303

  4. Spectral domain optical coherence tomography findings in acute posterior multifocal placoid pigment epitheliopathy

    Ocular Immunology and Inflammation, Vol. 19, Núm. 1, pp. 48-50

2010

  1. Asymptomatic oculocardiac reflex during phacoemulsification

    Acta Ophthalmologica

  2. Intravitreal bevacizumab and cataract surgery after wet age-related macular degeneration

    International Journal of Ophthalmology, Vol. 10, Núm. 7, pp. 1245-1247

  3. Intravitreal bevacizumab to treat myopic choroidal neovascularization: 2-Year outcome

    Graefe's Archive for Clinical and Experimental Ophthalmology, Vol. 248, Núm. 7, pp. 937-941